ESR1 mutation sub clonality means they are poorly representative of a patient’s cancer overall, limiting the potential for their ctDNA dynamics to predict clinical outcome (Fig. 3b, d; Supplementary Fig. 9). This evidence concerns the gene ESR1 and cancer.